Highlights and Quick Summary
- Beginning Cash for the quarter ending September 30, 2022 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Beginning Cash decreased by NaN%
- Annual Beginning Cash for 2020 was $24.1 Thousand (a -97.48% decrease from previous year)
- Twelve month Beginning Cash ending September 30, 2022 was $6.68 Million (a -0.36% decrease compared to previous quarter)
Trailing Beginning Cash for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | — |
|---|---|---|---|
| $6.68 Million | $6.7 Million | $7.65 Million | — |
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Beginning Cash of Bone Biologics Corp.
Most recent Beginning Cashof BBLG including historical data for past 10 years.Interactive Chart of Beginning Cash of Bone Biologics Corp.
Bone Biologics Corp. Beginning Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $6.68 | – |
| 2021 | – | – | – | $0.0 | – |
| 2020 | – | – | – | $0.02 | $0.02 |
| 2019 | $0.96 | – | – | – | $0.96 |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices